Novo Nordisk to affirm superiority of CagriSema in obesity market
Eli Lilly recently received FDA approval for Zepbound, a GLP-1 weekly injectable drug to treat obesity.
Eli Lilly recently received FDA approval for Zepbound, a GLP-1 weekly injectable drug to treat obesity.
Cradle, the biotech startup using generative AI to help scientists design and engineer proteins, has raised $24 million in Series A funding.
Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations are common in solid tumors, including lung cancer, colorectal cancer, and pancreatic ductal adenocarcinoma.